Appendix B
Open Meeting Agendas

Meeting I

April 3 and 4, 2000

The Foundry Building, Washington, D.C.

3 April 2000

10:00AM

Sponsor Presentation: Charge to the IOM and Welcoming Remarks

MG John S. Parker, M.D.,

Commanding General

U.S. Army Medical Research and Materiel Command

 

Overview of the Military Infectious Diseases Research Program

COL Charles H. Hoke, Jr., M.D.,

Research Area Director

Military Infectious Diseases Research Program

11:00AM

Break

11:15AM

Sponsor Presentation, continued

Overview of the DoD Research and Development (Acquisition) Model

COL Rodney A. Michael, M.D.

Research Area Deputy Director

Military Infectious Diseases Research Program



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 119
Protecting Our Forces: Improving Vaccine Acquisition and Availability in the U.S. Military Appendix B Open Meeting Agendas Meeting I April 3 and 4, 2000 The Foundry Building, Washington, D.C. 3 April 2000 10:00AM Sponsor Presentation: Charge to the IOM and Welcoming Remarks MG John S. Parker, M.D., Commanding General U.S. Army Medical Research and Materiel Command   Overview of the Military Infectious Diseases Research Program COL Charles H. Hoke, Jr., M.D., Research Area Director Military Infectious Diseases Research Program 11:00AM Break 11:15AM Sponsor Presentation, continued Overview of the DoD Research and Development (Acquisition) Model COL Rodney A. Michael, M.D. Research Area Deputy Director Military Infectious Diseases Research Program

OCR for page 119
Protecting Our Forces: Improving Vaccine Acquisition and Availability in the U.S. Military   Biologic Warfare Defense Research and Endemic Infectious Diseases Research: Whence and why the dichotomy COL John F. Glenn, Ph.D. Deputy for Research and Development U.S. Army Medical Research and Materiel Command 12:15PM Lunch 1:15PM Discussion with Sponsor: Current challenges Overview of the challenges to adequate vaccine strategy presented by industry and DoD policies and constraints Overview of the regulatory parameters that currently affect military vaccine strategy Discussion of what the U.S. Army seeks to gain from this committee report Discussion of charge 2:15PM Break, end of open session Meeting II June 19 and 20, 2000 The Foundry Building, Washington, D.C. 19 June 2000 10:00AM Welcome and Introduction Stanley Lemon, M.D., Chair 10:05AM Examples of the Impact of Vaccine Preventable Infectious Disease:   Impact of Recent Adenovirus Outbreaks in Military Training Centers CAPT Gregory Gray, M.D., M.P.H. Director, DoD Center for Deployment Health Research Naval Health Research Center, San Diego   Lt Col James Neville, M.D., M.P.H. Chief, Force Health Protection and Surveillance Branch U.S. Air Force Institute for Environment, Safety & Occupational Health Risk Analysis Brooks Air Force Base

OCR for page 119
Protecting Our Forces: Improving Vaccine Acquisition and Availability in the U.S. Military   Leonard N. Binn, Ph.D. Supervisory Research Microbiologist, Department of Virus Diseases Walter Reed Army Institute of Research   The Meningococcal Meningitis Situation, Military and Civilian Juliette Morgan, M.D. Medical Epidemiologist, Meningitis and Special Pathogens Branch Centers for Disease Control and Prevention   John Brundage, M.D., M.P.H. Senior Research Epidemiologist, Henry M. Jackson Foundation Army Medical Surveillance Activity Walter Reed Army Institute of Research 11:30AM JVAP—Procurement Process for Vaccines for Biowarfare Defense Richard B. Paul, M.A. Acting Program Manager, Joint Vaccine Acquisition Program 12:00PM Vaccine Development Success–Policy Failure Adenovirus Vaccine: Successful Development Franklin H. Top, Jr., M.D. Executive Vice President and Medical Director, MedImmune   Adenovirus Vaccine: A Policy Failure Joel Gaydos, M.D., M.P.H. DoD Global Emerging Infections Surveillance & Response System, Division of Preventive Medicine, Walter Reed Army Institute of Research 12:45PM Lunch (and continued discussion) 1:30PM Vaccine Research & Development: Priority Setting DoD Requirements Generation and Acquisition James H. Nelson, Ph.D. Director, U.S. Army Medical Materiel Development Activity   Military Medical Surveillance of Infectious Disease LTC Mark V. Rubertone, M.D., M.P.H. Chief, Army Medical Surveillance Activity U.S. Army Center for Health Promotion and Preventive Medicine

OCR for page 119
Protecting Our Forces: Improving Vaccine Acquisition and Availability in the U.S. Military   Medical Intelligence Deborah G. Keimig, Ph.D. Chief, Epidemiology and Environmental Health Division Armed Forces Medical Intelligence Center, Fort Detrick   Priority Setting in Practice COL Rodney A. Michael, M.D. Deputy Director, Military Infectious Disease Research Program   Discussion 4:00PM Open session ends 20 June 2000 7:30AM Continental Breakfast 8:00AM Review of Meeting Day 1 and Introduction of Day 2 Program Stanley Lemon, M.D., Chair 8:20AM Status of Limited Use Vaccines in the Military LTC Phillip R. Pittman, M.D., M.P.H. Senior Medical Scientist U.S. Army Research Institute of Infectious Diseases 8:50AM How Others (Try to) Make Limited Use Vaccine Development Work:   Food and Drug Administration Karen Goldenthal, M.D. Director, Division of Vaccines & Related Products Applications   National Institute of Allergy and Infectious Disease, National Institutes of Health Carole A. Heilman, Ph.D. Director, Division of Microbiology and Infectious Diseases   Centers for Disease Control and Prevention James W. LeDuc, Ph.D. Acting Director, Division of Viral and Rickettsial Diseases National Center for Infectious Diseases Centers for Disease Control and Prevention

OCR for page 119
Protecting Our Forces: Improving Vaccine Acquisition and Availability in the U.S. Military   Industry Involvement in Federal Vaccine Development and Procurement Efforts Thomas P. Monath, M.D. Vice President, Research & Medical Affairs, OraVax Inc.   Discussion: Constraints Faced and Handled How Might DoD Use These Approaches 11:45AM Lunch—with concurrent discussion based on morning’s presentations Open session ends Meeting III September 21 and 22, 2000 The Foundry Building, Washington, D.C. 21 September 2000 11:00AM Welcome Stanley Lemon, M.D., Chair 11:05AM Adenovirus vaccine MAJ Michael Dyer, M.S. Office of the TRADOC Surgeon William Howell Deputy for Acquisition and Advanced Development U.S. Army Medical Research and Materiel Command 12:00PM Lunch 12:45PM Vaccine production Gary Nabel, M.D., Ph.D. Director, NIH Vaccine Research Center Jack Melling, Ph.D. formerly with the Salk Institute and the Center for Applied Microbiology and Research 2:00PM Priorities LTC Brian G. Scott, M.D. Clinical Consultant, Force Protection AMEDD Center and School Directorate of Combat and Doctrine Development

OCR for page 119
Protecting Our Forces: Improving Vaccine Acquisition and Availability in the U.S. Military   COL John Frazier Glenn, Ph.D. Deputy for Research and Development U.S. Army Medical Research and Materiel Command   Discussion Presenters along with: COL Charles Hoke, Jr., M.D. COL Rodney Michael, M.D. 4:00PM Discussion 5:00PM Adjourn for the day Meeting IV November 13 and 14, 2000 The Foundry Building, Washington, D.C. 13 November 2000 9:30AM Continental breakfast in conference room 10:00AM Review agenda, introduce speakers 10:10AM Incentivizing limited use vaccine production: getting and keeping vaccines Kevin L. Reilly President, Wyeth Vaccines, Wyeth Pharmaceuticals 11:30AM Public release of this committee’s interim report: Urgent Attention Needed to Restore Lapsed Adenovirus Vaccine Availability: A Letter Report Stanley Lemon, M.D., Chair   Adenovirus update CDR Jeff Yund, M.D. Division of Preventive Medicine and Occupational Health U.S. Navy Bureau of Medicine and Surgery 12:30PM Working lunch in conference room for committee, staff, and guests 1:30PM Priority setting revisited (panel discussion) COL John Frazier Glenn, Ph.D. Deputy for Research and Development U.S. Army Medical Research and Materiel Command

OCR for page 119
Protecting Our Forces: Improving Vaccine Acquisition and Availability in the U.S. Military   LTC Brian G. Scott, M.D. Clinical Consultant, Force Protection Directorate of Combat and Doctrine Development AMEDD Center & School   COL Charles Hoke, Jr., M.D. Director, Military Infectious Diseases Research Program U.S. Army Medical Research and Materiel Command 3:00PM Open session ends Meeting V Tuesday, February 27, 2001 The Foundry Building, Washington, D.C. 12:00PM Working lunch in conference room for committee, staff, and guests 1:00PM Setting vaccine priorities in DoD Anna Johnson-Winegar, Ph.D. Deputy Assistant to the Secretary of Defense Counterproliferation and Chemical/Biological Defense 2:00PM Open session ends

OCR for page 119
Protecting Our Forces: Improving Vaccine Acquisition and Availability in the U.S. Military This page in the original is blank.